Skip to main content
Award Ceremony, SxDiagnostics
The two founders, Carolyn Krause (l) and Susanne Schmidt (r) at the award ceremony, with Heike Marzen, Managing Director of the Dortmund Economic Development Agency and Alexander Kalouti, Mayor of the City of Dortmund
© Wirtschaftsförderung Dortmund / Andreas Buck

News categories: Honors & Funding

start2grow start-up competition awards “SxDiagnostics”

The “SxDiagnostics” project from the University of Bonn and the University Hospital Bonn (UKB) prevailed against over 100 competing teams in the start2grow competition and placed in the (shared) 4th to 10th spots. Start2grow is organized nationwide by the Dortmund Economic Development Agency and celebrated its 25th anniversary this year.

“SxDiagnostics,” led by Dr. Susanne Schmidt and Carolyn Krause, will use the prize money to further develop its innovative “SIRS chip” for detecting certain inflammatory responses towards market-readiness. This blood-based method can be used to assess the risk of systemic inflammatory response syndrome (SIRS). SIRS is a life-threatening immune response that can occur after invasive surgery and lead to death. The resulting SIRS prognosis helps physicians implement advanced therapies against SIRS prior to surgery, thereby saving lives.

Start-up Momentum from the Medical Field

“We were thrilled to receive the start2grow award! Now we’re highly motivated to continue working on our business and financing plans and are looking for business administrators, sales professionals, lawyers, and regulatory experts who can actively support us in building our start-up,” says Dr. Susanne Schmidt. She heads the Immune Monitoring & Genomics working group at the Institute of Clinical Chemistry and Clinical Pharmacology at the UKB. With her start-up project, she has already secured a GO-Bio initial grant from the BMFTR and a prototyping grant from the University of Bonn in 2025. The transfer teams from the Transfer Center enaCom and the Faculty of Medicine are supporting her on her path to founding the company.

Awards Ceremony in Dortmund

For the grand finale of start2grow 2025, held in Dortmund in March 2026, 20 selected teams were invited to present their business models to a panel of experts from the business, academic, and financial sectors. Among the top 10 teams, SxDiagnostics is the only one from the medical field. The top three spots went to the start-ups Spree Monitoring GmbH—a monitoring system for bridges—cargovibe UG—solutions for truck drivers—and wailand—an AI platform for engineers. All participants are supported by experienced coaches and benefit from expert knowledge, networks, and a variety of events.

About start2grow

The nationwide start-up competition start2grow, organized by the Dortmund Economic Development Agency, supports founders and start-ups with innovative and technology-driven business models.

Contact

Dr. Susanne Schmidt
Institute of Clinical Chemistry and Clinical Pharmacology
University Hospital Bonn (UKB)
mail: susanne.schmidt@uni-bonn.de
phone: +49 228 28712102

website SxDiagnostics

Related news

News Marvin Supercomputer

News categories: Honors & Funding

Two years of the Marvin Supercomputer: Researchers in Bonn present their projects

Two years after it went into operation, the University of Bonn celebrated the Marvin Supercomputer with a community event at the Research and Technology Center for Detector Physics (FTD). Researchers from various disciplines presented projects that had been carried out using high-performance computing and used the event as an opportunity for interdisciplinary exchange. A team lead by ImmunoSensation³ members Prof. Dr. Michael Hölzel (Institute of Experimental Oncology) and PD Dr. Gregor Hagelueken (Institute of Structural Biology) use Marvin to design new proteins.
View entry
Gut

News categories: Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry
Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry

Back to the news overview